Skip to content
Recall Observatory FDA recall evidence

Drug product

Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-31

D-014-2014

September 04, 2013

Class II

Product summary

Firm
Pfizer Us Pharmaceutical Group
Event
Event 66124
Status
Terminated
Classification
Class II
Quantity
31 bottles
Official record key
drug-enforcement:D-014-2014

Official wording

Reason: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Code information: Lot #: V121573, Exp 05/17

Distribution pattern: US Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.